2022
DOI: 10.1002/dc.25072
|View full text |Cite
|
Sign up to set email alerts
|

A case of bone metastasis of hepatocellular carcinoma: Mallory hyaline bodies can lead to the correct cytological diagnosis

Abstract: Hepatocellular carcinoma (HCC) accounts for most primary tumors of the liver.Although bone metastasis does not occur in a high percentage of patients, bone metastasis is often found first, which leads to the diagnosis of HCC. In this report, we describe a case of bone metastasis from HCC in which bone lesions were detected incidentally, and in which a cytological diagnosis was difficult to make. The patient was a 78-year-old man with a history of renal dysfunction after orthopedic surgery.He underwent a thorou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…Those cytologic features are considered to reveal complete absence of highly atypical epithelial-like cells forming cohesive sheet-like and "three-dimensional" clusters [4]. Furthermore, the findings of the current immunohistochemical analyses suggest that immunostaining for specific epithelial markers, such as EMA, on sarcomatoid elements in cytological smears (i.e., immunocytochemistry) must be useful for the differential diagnosis with malignant phyllodes tumor or primary breast sarcomas [7][8][9].…”
Section: Discussionmentioning
confidence: 95%
“…Those cytologic features are considered to reveal complete absence of highly atypical epithelial-like cells forming cohesive sheet-like and "three-dimensional" clusters [4]. Furthermore, the findings of the current immunohistochemical analyses suggest that immunostaining for specific epithelial markers, such as EMA, on sarcomatoid elements in cytological smears (i.e., immunocytochemistry) must be useful for the differential diagnosis with malignant phyllodes tumor or primary breast sarcomas [7][8][9].…”
Section: Discussionmentioning
confidence: 95%
“…3 In addition, when submitted effusion is sufficiently available for various examinations, clinicians/cytopathologists should perform not only immunohistochemistry but flow cytometry or next-generation sequencing studies. 7 In fact, flow cytometry can also play a key role for confirmation of the final diagnosis of AITL effusion, after ruling out the differential diagnoses (including B-cell lymphoma, Hodgkin lymphoma, natural killer lymphoma, other T-cell lymphomas, poorly differentiated carcinoma, or malignant melanoma). Nevertheless, because of the insufficient/inadequate amount of submitted pleural effusion in the current case, only 10 mL, we were never able to make cell block sections or perform additional immunocytochemistry.…”
Section: Discussionmentioning
confidence: 99%
“…The expressions of follicular helper T‐cell markers, including PD‐1, CD10, bcl‐6 or CXCL‐13, are very useful for the definitive diagnosis of lymphomatous effusion caused by AITL, according to the first case report diagnosed by cell block immunohistochemistry 3 . In addition, when submitted effusion is sufficiently available for various examinations, clinicians/cytopathologists should perform not only immunohistochemistry but flow cytometry or next‐generation sequencing studies 7 . In fact, flow cytometry can also play a key role for confirmation of the final diagnosis of AITL effusion, after ruling out the differential diagnoses (including B‐cell lymphoma, Hodgkin lymphoma, natural killer lymphoma, other T‐cell lymphomas, poorly differentiated carcinoma, or malignant melanoma).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation